{"transactions":[{"id":3415934,"issuer":{"id":2888,"kind":"organization","name":"Medtronic plc","symbol":"MDT"},"owners":[{"id":155020,"kind":"person","name":"HAKAMI HOOMAN","position":1,"cik":"0001610035","reported_name":"HAKAMI HOOMAN","relationship":{"officer":true,"officer_title":"EVP & Group President Diabetes"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-09-12T17:55:34.000Z","date":"2019-09-10","kind":"exercise","acquired":false,"shares":423,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."}],"balance_after":1272,"derivative":{"exercise_price":89.08,"exercise_date":"2019-07-30","expiration_date":"2028-07-30","underlying":"Ordinary Shares","underlying_shares":423},"source":{"system":"sec-edgar","filing":"0001127602-19-028265","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":25,"url":"https://www.sec.gov/Archives/edgar/data/1610035/000112760219028265/form4.xml","form_type":"4"}},{"id":3415933,"issuer":{"id":2888,"kind":"organization","name":"Medtronic plc","symbol":"MDT"},"owners":[{"id":155020,"kind":"person","name":"HAKAMI HOOMAN","position":1,"cik":"0001610035","reported_name":"HAKAMI HOOMAN","relationship":{"officer":true,"officer_title":"EVP & Group President Diabetes"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-09-12T17:55:34.000Z","date":"2019-09-10","kind":"exercise","acquired":false,"shares":14121,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."}],"balance_after":42364,"derivative":{"exercise_price":89.08,"exercise_date":"2019-07-30","expiration_date":"2028-07-30","underlying":"Ordinary Shares","underlying_shares":14121},"source":{"system":"sec-edgar","filing":"0001127602-19-028265","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":24,"url":"https://www.sec.gov/Archives/edgar/data/1610035/000112760219028265/form4.xml","form_type":"4"}},{"id":3415932,"issuer":{"id":2888,"kind":"organization","name":"Medtronic plc","symbol":"MDT"},"owners":[{"id":155020,"kind":"person","name":"HAKAMI HOOMAN","position":1,"cik":"0001610035","reported_name":"HAKAMI HOOMAN","relationship":{"officer":true,"officer_title":"EVP & Group President Diabetes"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-09-12T17:55:34.000Z","date":"2019-09-10","kind":"exercise","acquired":false,"shares":595,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."}],"balance_after":596,"derivative":{"exercise_price":83.97,"exercise_date":"2018-07-31","expiration_date":"2027-07-31","underlying":"Ordinary Shares","underlying_shares":595},"source":{"system":"sec-edgar","filing":"0001127602-19-028265","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":23,"url":"https://www.sec.gov/Archives/edgar/data/1610035/000112760219028265/form4.xml","form_type":"4"}},{"id":3415931,"issuer":{"id":2888,"kind":"organization","name":"Medtronic plc","symbol":"MDT"},"owners":[{"id":155020,"kind":"person","name":"HAKAMI HOOMAN","position":1,"cik":"0001610035","reported_name":"HAKAMI HOOMAN","relationship":{"officer":true,"officer_title":"EVP & Group President Diabetes"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-09-12T17:55:34.000Z","date":"2019-09-10","kind":"exercise","acquired":false,"shares":19054,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."}],"balance_after":19055,"derivative":{"exercise_price":83.97,"exercise_date":"2018-07-31","expiration_date":"2027-07-31","underlying":"Ordinary Shares","underlying_shares":19054},"source":{"system":"sec-edgar","filing":"0001127602-19-028265","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":22,"url":"https://www.sec.gov/Archives/edgar/data/1610035/000112760219028265/form4.xml","form_type":"4"}},{"id":3415930,"issuer":{"id":2888,"kind":"organization","name":"Medtronic plc","symbol":"MDT"},"owners":[{"id":155020,"kind":"person","name":"HAKAMI HOOMAN","position":1,"cik":"0001610035","reported_name":"HAKAMI HOOMAN","relationship":{"officer":true,"officer_title":"EVP & Group President Diabetes"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-09-12T17:55:34.000Z","date":"2019-09-10","kind":"exercise","acquired":false,"shares":852,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."}],"balance_after":284,"derivative":{"exercise_price":88.06,"exercise_date":"2017-08-01","expiration_date":"2026-08-01","underlying":"Ordinary Shares","underlying_shares":852},"source":{"system":"sec-edgar","filing":"0001127602-19-028265","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":21,"url":"https://www.sec.gov/Archives/edgar/data/1610035/000112760219028265/form4.xml","form_type":"4"}},{"id":3415929,"issuer":{"id":2888,"kind":"organization","name":"Medtronic plc","symbol":"MDT"},"owners":[{"id":155020,"kind":"person","name":"HAKAMI HOOMAN","position":1,"cik":"0001610035","reported_name":"HAKAMI HOOMAN","relationship":{"officer":true,"officer_title":"EVP & Group President Diabetes"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-09-12T17:55:34.000Z","date":"2019-09-10","kind":"exercise","acquired":false,"shares":27254,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."}],"balance_after":9085,"derivative":{"exercise_price":88.06,"exercise_date":"2017-08-01","expiration_date":"2026-08-01","underlying":"Ordinary Shares","underlying_shares":27254},"source":{"system":"sec-edgar","filing":"0001127602-19-028265","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":20,"url":"https://www.sec.gov/Archives/edgar/data/1610035/000112760219028265/form4.xml","form_type":"4"}},{"id":3415928,"issuer":{"id":2888,"kind":"organization","name":"Medtronic plc","symbol":"MDT"},"owners":[{"id":155020,"kind":"person","name":"HAKAMI HOOMAN","position":1,"cik":"0001610035","reported_name":"HAKAMI HOOMAN","relationship":{"officer":true,"officer_title":"EVP & Group President Diabetes"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-09-12T17:55:34.000Z","date":"2019-09-10","kind":"exercise","acquired":false,"shares":321,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"These options to purchase ordinary shares of New Medtronic for $62.76 per share, which were unvested at the effective time of the Merger, were received in the Merger and represent the conversion of an equal number of Medtronic common stock shares for $62.76 per share.  The New Medtronic stock option has the same terms and conditions as the original Medtronic stock option. These options became exercisable in four equal annual installments beginning on July 28, 2015, which was the first anniversary of the grant."}],"balance_after":0,"derivative":{"exercise_price":78,"exercise_date":"2016-08-03","expiration_date":"2025-08-03","underlying":"Ordinary Shares","underlying_shares":321},"source":{"system":"sec-edgar","filing":"0001127602-19-028265","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":19,"url":"https://www.sec.gov/Archives/edgar/data/1610035/000112760219028265/form4.xml","form_type":"4"}},{"id":3415927,"issuer":{"id":2888,"kind":"organization","name":"Medtronic plc","symbol":"MDT"},"owners":[{"id":155020,"kind":"person","name":"HAKAMI HOOMAN","position":1,"cik":"0001610035","reported_name":"HAKAMI HOOMAN","relationship":{"officer":true,"officer_title":"EVP & Group President Diabetes"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-09-12T17:55:34.000Z","date":"2019-09-10","kind":"exercise","acquired":false,"shares":10257,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"These options to purchase ordinary shares of New Medtronic for $62.76 per share, which were unvested at the effective time of the Merger, were received in the Merger and represent the conversion of an equal number of Medtronic common stock shares for $62.76 per share.  The New Medtronic stock option has the same terms and conditions as the original Medtronic stock option. These options became exercisable in four equal annual installments beginning on July 28, 2015, which was the first anniversary of the grant."}],"balance_after":321,"derivative":{"exercise_price":78,"exercise_date":"2016-08-03","expiration_date":"2025-08-03","underlying":"Ordinary Shares","underlying_shares":10257},"source":{"system":"sec-edgar","filing":"0001127602-19-028265","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":18,"url":"https://www.sec.gov/Archives/edgar/data/1610035/000112760219028265/form4.xml","form_type":"4"}},{"id":3415926,"issuer":{"id":2888,"kind":"organization","name":"Medtronic plc","symbol":"MDT"},"owners":[{"id":155020,"kind":"person","name":"HAKAMI HOOMAN","position":1,"cik":"0001610035","reported_name":"HAKAMI HOOMAN","relationship":{"officer":true,"officer_title":"EVP & Group President Diabetes"}}],"security":"Ordinary Shares","published_at":"2019-09-12T17:55:34.000Z","date":"2019-09-10","kind":"sale","acquired":false,"shares":423,"price":107.22,"value":45354.06,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."}],"balance_after":30761,"source":{"system":"sec-edgar","filing":"0001127602-19-028265","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":17,"url":"https://www.sec.gov/Archives/edgar/data/1610035/000112760219028265/form4.xml","form_type":"4"}},{"id":3415925,"issuer":{"id":2888,"kind":"organization","name":"Medtronic plc","symbol":"MDT"},"owners":[{"id":155020,"kind":"person","name":"HAKAMI HOOMAN","position":1,"cik":"0001610035","reported_name":"HAKAMI HOOMAN","relationship":{"officer":true,"officer_title":"EVP & Group President Diabetes"}}],"security":"Ordinary Shares","published_at":"2019-09-12T17:55:34.000Z","date":"2019-09-10","kind":"exercise","acquired":true,"shares":423,"price":89.08,"value":37680.84,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."}],"balance_after":31184,"source":{"system":"sec-edgar","filing":"0001127602-19-028265","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":16,"url":"https://www.sec.gov/Archives/edgar/data/1610035/000112760219028265/form4.xml","form_type":"4"}},{"id":3415924,"issuer":{"id":2888,"kind":"organization","name":"Medtronic plc","symbol":"MDT"},"owners":[{"id":155020,"kind":"person","name":"HAKAMI HOOMAN","position":1,"cik":"0001610035","reported_name":"HAKAMI HOOMAN","relationship":{"officer":true,"officer_title":"EVP & Group President Diabetes"}}],"security":"Ordinary Shares","published_at":"2019-09-12T17:55:34.000Z","date":"2019-09-10","kind":"sale","acquired":false,"shares":14121,"price":107.412,"value":1516764.852,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The price reported in Column 4 is a weighted average price.  The shares were sold in multiple transactions at prices ranging from $107.36 to $107.48, inclusive.  The reporting person undertakes to provide to Medtronic plc, any security holder of Medtronic plc, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":30761,"source":{"system":"sec-edgar","filing":"0001127602-19-028265","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":15,"url":"https://www.sec.gov/Archives/edgar/data/1610035/000112760219028265/form4.xml","form_type":"4"}},{"id":3415923,"issuer":{"id":2888,"kind":"organization","name":"Medtronic plc","symbol":"MDT"},"owners":[{"id":155020,"kind":"person","name":"HAKAMI HOOMAN","position":1,"cik":"0001610035","reported_name":"HAKAMI HOOMAN","relationship":{"officer":true,"officer_title":"EVP & Group President Diabetes"}}],"security":"Ordinary Shares","published_at":"2019-09-12T17:55:34.000Z","date":"2019-09-10","kind":"exercise","acquired":true,"shares":14121,"price":89.08,"value":1257898.68,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."}],"balance_after":44882,"source":{"system":"sec-edgar","filing":"0001127602-19-028265","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":14,"url":"https://www.sec.gov/Archives/edgar/data/1610035/000112760219028265/form4.xml","form_type":"4"}},{"id":3415922,"issuer":{"id":2888,"kind":"organization","name":"Medtronic plc","symbol":"MDT"},"owners":[{"id":155020,"kind":"person","name":"HAKAMI HOOMAN","position":1,"cik":"0001610035","reported_name":"HAKAMI HOOMAN","relationship":{"officer":true,"officer_title":"EVP & Group President Diabetes"}}],"security":"Ordinary Shares","published_at":"2019-09-12T17:55:34.000Z","date":"2019-09-10","kind":"sale","acquired":false,"shares":595,"price":107.22,"value":63795.9,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."}],"balance_after":30761,"source":{"system":"sec-edgar","filing":"0001127602-19-028265","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/1610035/000112760219028265/form4.xml","form_type":"4"}},{"id":3415921,"issuer":{"id":2888,"kind":"organization","name":"Medtronic plc","symbol":"MDT"},"owners":[{"id":155020,"kind":"person","name":"HAKAMI HOOMAN","position":1,"cik":"0001610035","reported_name":"HAKAMI HOOMAN","relationship":{"officer":true,"officer_title":"EVP & Group President Diabetes"}}],"security":"Ordinary Shares","published_at":"2019-09-12T17:55:34.000Z","date":"2019-09-10","kind":"exercise","acquired":true,"shares":595,"price":83.97,"value":49962.15,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."}],"balance_after":31356,"source":{"system":"sec-edgar","filing":"0001127602-19-028265","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1610035/000112760219028265/form4.xml","form_type":"4"}},{"id":3415920,"issuer":{"id":2888,"kind":"organization","name":"Medtronic plc","symbol":"MDT"},"owners":[{"id":155020,"kind":"person","name":"HAKAMI HOOMAN","position":1,"cik":"0001610035","reported_name":"HAKAMI HOOMAN","relationship":{"officer":true,"officer_title":"EVP & Group President Diabetes"}}],"security":"Ordinary Shares","published_at":"2019-09-12T17:55:34.000Z","date":"2019-09-10","kind":"sale","acquired":false,"shares":19054,"price":107.414,"value":2046666.356,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price.  The shares were sold in multiple transactions at prices ranging from $107.28 to $107.58, inclusive.  The reporting person undertakes to provide to Medtronic plc, any security holder of Medtronic plc, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":30761,"source":{"system":"sec-edgar","filing":"0001127602-19-028265","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1610035/000112760219028265/form4.xml","form_type":"4"}},{"id":3415919,"issuer":{"id":2888,"kind":"organization","name":"Medtronic plc","symbol":"MDT"},"owners":[{"id":155020,"kind":"person","name":"HAKAMI HOOMAN","position":1,"cik":"0001610035","reported_name":"HAKAMI HOOMAN","relationship":{"officer":true,"officer_title":"EVP & Group President Diabetes"}}],"security":"Ordinary Shares","published_at":"2019-09-12T17:55:34.000Z","date":"2019-09-10","kind":"exercise","acquired":true,"shares":19054,"price":83.97,"value":1599964.38,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."}],"balance_after":49815,"source":{"system":"sec-edgar","filing":"0001127602-19-028265","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1610035/000112760219028265/form4.xml","form_type":"4"}},{"id":3415918,"issuer":{"id":2888,"kind":"organization","name":"Medtronic plc","symbol":"MDT"},"owners":[{"id":155020,"kind":"person","name":"HAKAMI HOOMAN","position":1,"cik":"0001610035","reported_name":"HAKAMI HOOMAN","relationship":{"officer":true,"officer_title":"EVP & Group President Diabetes"}}],"security":"Ordinary Shares","published_at":"2019-09-12T17:55:34.000Z","date":"2019-09-10","kind":"sale","acquired":false,"shares":852,"price":107.22,"value":91351.44,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."}],"balance_after":30761,"source":{"system":"sec-edgar","filing":"0001127602-19-028265","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1610035/000112760219028265/form4.xml","form_type":"4"}},{"id":3415917,"issuer":{"id":2888,"kind":"organization","name":"Medtronic plc","symbol":"MDT"},"owners":[{"id":155020,"kind":"person","name":"HAKAMI HOOMAN","position":1,"cik":"0001610035","reported_name":"HAKAMI HOOMAN","relationship":{"officer":true,"officer_title":"EVP & Group President Diabetes"}}],"security":"Ordinary Shares","published_at":"2019-09-12T17:55:34.000Z","date":"2019-09-10","kind":"exercise","acquired":true,"shares":852,"price":88.06,"value":75027.12,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."}],"balance_after":31613,"source":{"system":"sec-edgar","filing":"0001127602-19-028265","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1610035/000112760219028265/form4.xml","form_type":"4"}},{"id":3415916,"issuer":{"id":2888,"kind":"organization","name":"Medtronic plc","symbol":"MDT"},"owners":[{"id":155020,"kind":"person","name":"HAKAMI HOOMAN","position":1,"cik":"0001610035","reported_name":"HAKAMI HOOMAN","relationship":{"officer":true,"officer_title":"EVP & Group President Diabetes"}}],"security":"Ordinary Shares","published_at":"2019-09-12T17:55:34.000Z","date":"2019-09-10","kind":"sale","acquired":false,"shares":27254,"price":107.282,"value":2923863.628,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price.  The shares were sold in multiple transactions at prices ranging from $107.07 to $107.47, inclusive.  The reporting person undertakes to provide to Medtronic plc, any security holder of Medtronic plc, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":30761,"source":{"system":"sec-edgar","filing":"0001127602-19-028265","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1610035/000112760219028265/form4.xml","form_type":"4"}},{"id":3415915,"issuer":{"id":2888,"kind":"organization","name":"Medtronic plc","symbol":"MDT"},"owners":[{"id":155020,"kind":"person","name":"HAKAMI HOOMAN","position":1,"cik":"0001610035","reported_name":"HAKAMI HOOMAN","relationship":{"officer":true,"officer_title":"EVP & Group President Diabetes"}}],"security":"Ordinary Shares","published_at":"2019-09-12T17:55:34.000Z","date":"2019-09-10","kind":"exercise","acquired":true,"shares":27254,"price":88.06,"value":2399987.24,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."}],"balance_after":58015,"source":{"system":"sec-edgar","filing":"0001127602-19-028265","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1610035/000112760219028265/form4.xml","form_type":"4"}},{"id":3415914,"issuer":{"id":2888,"kind":"organization","name":"Medtronic plc","symbol":"MDT"},"owners":[{"id":155020,"kind":"person","name":"HAKAMI HOOMAN","position":1,"cik":"0001610035","reported_name":"HAKAMI HOOMAN","relationship":{"officer":true,"officer_title":"EVP & Group President Diabetes"}}],"security":"Ordinary Shares","published_at":"2019-09-12T17:55:34.000Z","date":"2019-09-10","kind":"sale","acquired":false,"shares":321,"price":107.22,"value":34417.62,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."}],"balance_after":30761,"source":{"system":"sec-edgar","filing":"0001127602-19-028265","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1610035/000112760219028265/form4.xml","form_type":"4"}},{"id":3415913,"issuer":{"id":2888,"kind":"organization","name":"Medtronic plc","symbol":"MDT"},"owners":[{"id":155020,"kind":"person","name":"HAKAMI HOOMAN","position":1,"cik":"0001610035","reported_name":"HAKAMI HOOMAN","relationship":{"officer":true,"officer_title":"EVP & Group President Diabetes"}}],"security":"Ordinary Shares","published_at":"2019-09-12T17:55:34.000Z","date":"2019-09-10","kind":"exercise","acquired":true,"shares":321,"price":78,"value":25038.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."}],"balance_after":31082,"source":{"system":"sec-edgar","filing":"0001127602-19-028265","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1610035/000112760219028265/form4.xml","form_type":"4"}},{"id":3415912,"issuer":{"id":2888,"kind":"organization","name":"Medtronic plc","symbol":"MDT"},"owners":[{"id":155020,"kind":"person","name":"HAKAMI HOOMAN","position":1,"cik":"0001610035","reported_name":"HAKAMI HOOMAN","relationship":{"officer":true,"officer_title":"EVP & Group President Diabetes"}}],"security":"Ordinary Shares","published_at":"2019-09-12T17:55:34.000Z","date":"2019-09-10","kind":"sale","acquired":false,"shares":10257,"price":107.307,"value":1100647.899,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price.  The shares were sold in multiple transactions at prices ranging from $107.10 to $107.43, inclusive.  The reporting person undertakes to provide to Medtronic plc, any security holder of Medtronic plc, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":30761,"source":{"system":"sec-edgar","filing":"0001127602-19-028265","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1610035/000112760219028265/form4.xml","form_type":"4"}},{"id":3415911,"issuer":{"id":2888,"kind":"organization","name":"Medtronic plc","symbol":"MDT"},"owners":[{"id":155020,"kind":"person","name":"HAKAMI HOOMAN","position":1,"cik":"0001610035","reported_name":"HAKAMI HOOMAN","relationship":{"officer":true,"officer_title":"EVP & Group President Diabetes"}}],"security":"Ordinary Shares","published_at":"2019-09-12T17:55:34.000Z","date":"2019-09-10","kind":"exercise","acquired":true,"shares":10257,"price":78,"value":800046.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."}],"balance_after":41018,"source":{"system":"sec-edgar","filing":"0001127602-19-028265","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1610035/000112760219028265/form4.xml","form_type":"4"}},{"id":3415910,"issuer":{"id":2888,"kind":"organization","name":"Medtronic plc","symbol":"MDT"},"owners":[{"id":155020,"kind":"person","name":"HAKAMI HOOMAN","position":1,"cik":"0001610035","reported_name":"HAKAMI HOOMAN","relationship":{"officer":true,"officer_title":"EVP & Group President Diabetes"}}],"security":"Ordinary Shares","published_at":"2019-09-12T17:55:34.000Z","date":"2019-09-10","kind":"sale","acquired":false,"shares":10000,"price":107.085,"value":1070850.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price.  The shares were sold in multiple transactions at prices ranging from $107.00 to $107.39, inclusive.  The reporting person undertakes to provide to Medtronic plc, any security holder of Medtronic plc, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":30761,"source":{"system":"sec-edgar","filing":"0001127602-19-028265","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1610035/000112760219028265/form4.xml","form_type":"4"}},{"id":3448722,"issuer":{"id":2888,"kind":"organization","name":"Medtronic plc","symbol":"MDT"},"owners":[{"id":155020,"kind":"person","name":"HAKAMI HOOMAN","position":1,"cik":"0001610035","reported_name":"HAKAMI HOOMAN","relationship":{"officer":true,"officer_title":"EVP & Group President Diabetes"}}],"security":"Ordinary Shares","published_at":"2019-08-02T18:13:33.000Z","date":"2019-08-01","kind":"tax_withholding","acquired":false,"shares":5703,"price":102.37,"value":583816.11,"ownership":{"direct":true},"balance_after":40761,"source":{"system":"sec-edgar","filing":"0001127602-19-025930","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1610035/000112760219025930/form4.xml","form_type":"4"}},{"id":3448721,"issuer":{"id":2888,"kind":"organization","name":"Medtronic plc","symbol":"MDT"},"owners":[{"id":155020,"kind":"person","name":"HAKAMI HOOMAN","position":1,"cik":"0001610035","reported_name":"HAKAMI HOOMAN","relationship":{"officer":true,"officer_title":"EVP & Group President Diabetes"}}],"security":"Ordinary Shares","published_at":"2019-08-02T18:13:33.000Z","date":"2019-08-01","kind":"tax_withholding","acquired":false,"shares":4562,"price":102.37,"value":467011.94,"ownership":{"direct":true},"balance_after":46464,"source":{"system":"sec-edgar","filing":"0001127602-19-025930","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1610035/000112760219025930/form4.xml","form_type":"4"}},{"id":3451729,"issuer":{"id":2888,"kind":"organization","name":"Medtronic plc","symbol":"MDT"},"owners":[{"id":155020,"kind":"person","name":"HAKAMI HOOMAN","position":1,"cik":"0001610035","reported_name":"HAKAMI HOOMAN","relationship":{"officer":true,"officer_title":"EVP & Group President Diabetes"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-07-31T17:50:08.000Z","date":"2019-07-29","kind":"grant","acquired":true,"shares":1615,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"These options become exercisable at the rate of 25% of the shares granted per year beginning on the first anniversary of grant."}],"balance_after":1615,"derivative":{"exercise_price":103.26,"exercise_date":"2020-07-29","expiration_date":"2029-07-29","underlying":"Ordinary Shares","underlying_shares":1615},"source":{"system":"sec-edgar","filing":"0001127602-19-025553","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1610035/000112760219025553/form4.xml","form_type":"4"}},{"id":3451728,"issuer":{"id":2888,"kind":"organization","name":"Medtronic plc","symbol":"MDT"},"owners":[{"id":155020,"kind":"person","name":"HAKAMI HOOMAN","position":1,"cik":"0001610035","reported_name":"HAKAMI HOOMAN","relationship":{"officer":true,"officer_title":"EVP & Group President Diabetes"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-07-31T17:50:08.000Z","date":"2019-07-29","kind":"grant","acquired":true,"shares":53829,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"These options become exercisable at the rate of 25% of the shares granted per year beginning on the first anniversary of grant."}],"balance_after":53829,"derivative":{"exercise_price":103.26,"exercise_date":"2020-07-29","expiration_date":"2029-07-29","underlying":"Ordinary Shares","underlying_shares":53829},"source":{"system":"sec-edgar","filing":"0001127602-19-025553","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1610035/000112760219025553/form4.xml","form_type":"4"}},{"id":3451727,"issuer":{"id":2888,"kind":"organization","name":"Medtronic plc","symbol":"MDT"},"owners":[{"id":155020,"kind":"person","name":"HAKAMI HOOMAN","position":1,"cik":"0001610035","reported_name":"HAKAMI HOOMAN","relationship":{"officer":true,"officer_title":"EVP & Group President Diabetes"}}],"security":"Ordinary Shares","published_at":"2019-07-31T17:50:08.000Z","date":"2019-07-29","kind":"grant","acquired":true,"shares":8071,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The restrictions on these restricted stock units shall lapse 100% on the third anniversary of the Grant Date if the Company's cumulative non-GAAP diluted earnings per share (\"EPS\") growth during the 36-month period ending on the last day of the Company's fiscal year 2022 equals or exceeds a 3% cumulative compound annual growth rate, as determined by the Compensation Committee."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"This balance increased by 282 shares due to exempt transactions such as dividend reinvestment and employee stock purchase plan."}],"balance_after":51026,"source":{"system":"sec-edgar","filing":"0001127602-19-025553","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1610035/000112760219025553/form4.xml","form_type":"4"}},{"id":3489065,"issuer":{"id":2888,"kind":"organization","name":"Medtronic plc","symbol":"MDT"},"owners":[{"id":155020,"kind":"person","name":"HAKAMI HOOMAN","position":1,"cik":"0001610035","reported_name":"HAKAMI HOOMAN","relationship":{"officer":true,"officer_title":"EVP & Group President Diabetes"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-06-14T16:51:21.000Z","date":"2019-06-12","kind":"exercise","acquired":false,"shares":31731,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"These options to purchase ordinary shares of New Medtronic for $62.76 per share, which were unvested at the effective time of the Merger, were received in the Merger and represent the conversion of an equal number of Medtronic common stock shares for $62.76 per share.  The New Medtronic stock option has the same terms and conditions as the original Medtronic stock option. These options became exercisable in four equal annual installments beginning on July 28, 2015, which was the first anniversary of the grant."}],"balance_after":10578,"derivative":{"exercise_price":78,"exercise_date":"2016-08-03","expiration_date":"2025-08-03","underlying":"Ordinary Shares","underlying_shares":31731},"source":{"system":"sec-edgar","filing":"0001127602-19-021658","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1610035/000112760219021658/form4.xml","form_type":"4"}},{"id":3489064,"issuer":{"id":2888,"kind":"organization","name":"Medtronic plc","symbol":"MDT"},"owners":[{"id":155020,"kind":"person","name":"HAKAMI HOOMAN","position":1,"cik":"0001610035","reported_name":"HAKAMI HOOMAN","relationship":{"officer":true,"officer_title":"EVP & Group President Diabetes"}}],"security":"Ordinary Shares","published_at":"2019-06-14T16:51:21.000Z","date":"2019-06-12","kind":"sale","acquired":false,"shares":20933,"price":97.49,"value":2040758.17,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price.  The shares were sold in multiple transactions at prices ranging from $97.23 to $97.95, inclusive.  The reporting person undertakes to provide to Medtronic plc, any security holder of Medtronic plc, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"This balance increased by 959 shares due to exempt transactions such as dividend reinvestment and Employee Stock Purchase Plan."}],"balance_after":42673,"source":{"system":"sec-edgar","filing":"0001127602-19-021658","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1610035/000112760219021658/form4.xml","form_type":"4"}},{"id":3489063,"issuer":{"id":2888,"kind":"organization","name":"Medtronic plc","symbol":"MDT"},"owners":[{"id":155020,"kind":"person","name":"HAKAMI HOOMAN","position":1,"cik":"0001610035","reported_name":"HAKAMI HOOMAN","relationship":{"officer":true,"officer_title":"EVP & Group President Diabetes"}}],"security":"Ordinary Shares","published_at":"2019-06-14T16:51:21.000Z","date":"2019-06-12","kind":"sale","acquired":false,"shares":31731,"price":97.49,"value":3093455.19,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price.  The shares were sold in multiple transactions at prices ranging from $97.22 to $97.96, inclusive.  The reporting person undertakes to provide to Medtronic plc, any security holder of Medtronic plc, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":63606,"source":{"system":"sec-edgar","filing":"0001127602-19-021658","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1610035/000112760219021658/form4.xml","form_type":"4"}},{"id":3489062,"issuer":{"id":2888,"kind":"organization","name":"Medtronic plc","symbol":"MDT"},"owners":[{"id":155020,"kind":"person","name":"HAKAMI HOOMAN","position":1,"cik":"0001610035","reported_name":"HAKAMI HOOMAN","relationship":{"officer":true,"officer_title":"EVP & Group President Diabetes"}}],"security":"Ordinary Shares","published_at":"2019-06-14T16:51:21.000Z","date":"2019-06-12","kind":"exercise","acquired":true,"shares":31731,"price":78,"value":2475018.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."}],"balance_after":95337,"source":{"system":"sec-edgar","filing":"0001127602-19-021658","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1610035/000112760219021658/form4.xml","form_type":"4"}},{"id":3824808,"issuer":{"id":2888,"kind":"organization","name":"Medtronic plc","symbol":"MDT"},"owners":[{"id":155020,"kind":"person","name":"HAKAMI HOOMAN","position":1,"cik":"0001610035","reported_name":"HAKAMI HOOMAN","relationship":{"officer":true,"officer_title":"EVP & Group President Diabetes"}}],"security":"Stock Option (Right to Buy)","published_at":"2018-09-05T16:33:30.000Z","date":"2018-08-31","kind":"exercise","acquired":false,"shares":18324,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"These options to purchase ordinary shares of New Medtronic for $62.76 per share, which were unvested at the effective time of the Merger, were received in the Merger and represent the conversion of an equal number of Medtronic common stock shares for $62.76 per share.  The New Medtronic stock option has the same terms and conditions as the original Medtronic stock option. These options became exercisable in four equal annual installments beginning on July 28, 2015, which was the first anniversary of the grant."}],"balance_after":0,"derivative":{"exercise_price":62.76,"expiration_date":"2024-07-28","underlying":"Ordinary Shares","underlying_shares":18324},"source":{"system":"sec-edgar","filing":"0001127602-18-026803","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1610035/000112760218026803/form4.xml","form_type":"4"}},{"id":3824807,"issuer":{"id":2888,"kind":"organization","name":"Medtronic plc","symbol":"MDT"},"owners":[{"id":155020,"kind":"person","name":"HAKAMI HOOMAN","position":1,"cik":"0001610035","reported_name":"HAKAMI HOOMAN","relationship":{"officer":true,"officer_title":"EVP & Group President Diabetes"}}],"security":"Stock Option (Right to Buy)","published_at":"2018-09-05T16:33:30.000Z","date":"2018-08-31","kind":"exercise","acquired":false,"shares":7436,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"These options to purchase ordinary shares of New Medtronic for $62.76 per share, which were unvested at the effective time of the Merger, were received in the Merger and represent the conversion of an equal number of Medtronic common stock shares for $62.76 per share.  The New Medtronic stock option has the same terms and conditions as the original Medtronic stock option. These options became exercisable in four equal annual installments beginning on July 28, 2015, which was the first anniversary of the grant."}],"balance_after":0,"derivative":{"exercise_price":62.76,"expiration_date":"2024-07-28","underlying":"Ordinary Shares","underlying_shares":7436},"source":{"system":"sec-edgar","filing":"0001127602-18-026803","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1610035/000112760218026803/form4.xml","form_type":"4"}},{"id":3824806,"issuer":{"id":2888,"kind":"organization","name":"Medtronic plc","symbol":"MDT"},"owners":[{"id":155020,"kind":"person","name":"HAKAMI HOOMAN","position":1,"cik":"0001610035","reported_name":"HAKAMI HOOMAN","relationship":{"officer":true,"officer_title":"EVP & Group President Diabetes"}}],"security":"Stock Option (Right to Buy)","published_at":"2018-09-05T16:33:30.000Z","date":"2018-08-31","kind":"exercise","acquired":false,"shares":399,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"These options to purchase ordinary shares of New Medtronic for $62.76 per share, which were unvested at the effective time of the Merger, were received in the Merger and represent the conversion of an equal number of Medtronic common stock shares for $62.76 per share.  The New Medtronic stock option has the same terms and conditions as the original Medtronic stock option. These options became exercisable in four equal annual installments beginning on July 28, 2015, which was the first anniversary of the grant."}],"balance_after":0,"derivative":{"exercise_price":62.76,"expiration_date":"2024-07-28","underlying":"Ordinary Shares","underlying_shares":399},"source":{"system":"sec-edgar","filing":"0001127602-18-026803","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1610035/000112760218026803/form4.xml","form_type":"4"}},{"id":3824805,"issuer":{"id":2888,"kind":"organization","name":"Medtronic plc","symbol":"MDT"},"owners":[{"id":155020,"kind":"person","name":"HAKAMI HOOMAN","position":1,"cik":"0001610035","reported_name":"HAKAMI HOOMAN","relationship":{"officer":true,"officer_title":"EVP & Group President Diabetes"}}],"security":"Ordinary Shares","published_at":"2018-09-05T16:33:30.000Z","date":"2018-08-31","kind":"sale","acquired":false,"shares":26159,"price":96.288,"value":2518797.792,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price.  The shares were sold in multiple transactions at prices ranging from $96.04 to $96.44, inclusive.  The reporting person undertakes to provide to Medtronic plc, any security holder of Medtronic plc, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":62647,"source":{"system":"sec-edgar","filing":"0001127602-18-026803","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1610035/000112760218026803/form4.xml","form_type":"4"}},{"id":3824804,"issuer":{"id":2888,"kind":"organization","name":"Medtronic plc","symbol":"MDT"},"owners":[{"id":155020,"kind":"person","name":"HAKAMI HOOMAN","position":1,"cik":"0001610035","reported_name":"HAKAMI HOOMAN","relationship":{"officer":true,"officer_title":"EVP & Group President Diabetes"}}],"security":"Ordinary Shares","published_at":"2018-09-05T16:33:30.000Z","date":"2018-08-31","kind":"exercise","acquired":true,"shares":18324,"price":62.76,"value":1150014.24,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."}],"balance_after":88806,"source":{"system":"sec-edgar","filing":"0001127602-18-026803","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1610035/000112760218026803/form4.xml","form_type":"4"}},{"id":3824803,"issuer":{"id":2888,"kind":"organization","name":"Medtronic plc","symbol":"MDT"},"owners":[{"id":155020,"kind":"person","name":"HAKAMI HOOMAN","position":1,"cik":"0001610035","reported_name":"HAKAMI HOOMAN","relationship":{"officer":true,"officer_title":"EVP & Group President Diabetes"}}],"security":"Ordinary Shares","published_at":"2018-09-05T16:33:30.000Z","date":"2018-08-31","kind":"exercise","acquired":true,"shares":7436,"price":62.76,"value":466683.36,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."}],"balance_after":70482,"source":{"system":"sec-edgar","filing":"0001127602-18-026803","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1610035/000112760218026803/form4.xml","form_type":"4"}},{"id":3824802,"issuer":{"id":2888,"kind":"organization","name":"Medtronic plc","symbol":"MDT"},"owners":[{"id":155020,"kind":"person","name":"HAKAMI HOOMAN","position":1,"cik":"0001610035","reported_name":"HAKAMI HOOMAN","relationship":{"officer":true,"officer_title":"EVP & Group President Diabetes"}}],"security":"Ordinary Shares","published_at":"2018-09-05T16:33:30.000Z","date":"2018-08-31","kind":"exercise","acquired":true,"shares":399,"price":62.76,"value":25041.24,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."}],"balance_after":63046,"source":{"system":"sec-edgar","filing":"0001127602-18-026803","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1610035/000112760218026803/form4.xml","form_type":"4"}},{"id":3850538,"issuer":{"id":2888,"kind":"organization","name":"Medtronic plc","symbol":"MDT"},"owners":[{"id":155020,"kind":"person","name":"HAKAMI HOOMAN","position":1,"cik":"0001610035","reported_name":"HAKAMI HOOMAN","relationship":{"officer":true,"officer_title":"EVP & Group President Diabetes"}}],"security":"Ordinary Shares","published_at":"2018-08-07T16:30:50.000Z","date":"2018-08-03","kind":"tax_withholding","acquired":false,"shares":4822,"price":90.48,"value":436294.56,"ownership":{"direct":true},"balance_after":62647,"source":{"system":"sec-edgar","filing":"0001127602-18-024844","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1610035/000112760218024844/form4.xml","form_type":"4"}},{"id":3854583,"issuer":{"id":2888,"kind":"organization","name":"Medtronic plc","symbol":"MDT"},"owners":[{"id":155020,"kind":"person","name":"HAKAMI HOOMAN","position":1,"cik":"0001610035","reported_name":"HAKAMI HOOMAN","relationship":{"officer":true,"officer_title":"EVP & Group President Diabetes"}}],"security":"Ordinary Shares","published_at":"2018-08-02T17:22:55.000Z","date":"2018-07-28","kind":"tax_withholding","acquired":false,"shares":9042,"price":88.66,"value":801663.72,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Too many tax shares were initially withheld in error.  This has been corrected from 10038 to 9042."}],"balance_after":58113,"source":{"system":"sec-edgar","filing":"0001127602-18-024486","document":"form4a.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1610035/000112760218024486/form4a.xml","form_type":"4/A","original_submission_date":"2018-07-31"}},{"id":3856442,"issuer":{"id":2888,"kind":"organization","name":"Medtronic plc","symbol":"MDT"},"owners":[{"id":155020,"kind":"person","name":"HAKAMI HOOMAN","position":1,"cik":"0001610035","reported_name":"HAKAMI HOOMAN","relationship":{"officer":true,"officer_title":"EVP & Group President Diabetes"}}],"security":"Stock Option (Right to Buy)","published_at":"2018-08-01T15:47:00.000Z","date":"2018-07-30","kind":"grant","acquired":true,"shares":1695,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These options become exercisable at the rate of 25% of the shares granted per year beginning on the first anniversary of grant."}],"balance_after":1695,"derivative":{"exercise_price":89.08,"exercise_date":"2019-07-30","expiration_date":"2028-07-30","underlying":"Ordinary Shares","underlying_shares":1695},"source":{"system":"sec-edgar","filing":"0001127602-18-024239","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1610035/000112760218024239/form4.xml","form_type":"4"}},{"id":3856441,"issuer":{"id":2888,"kind":"organization","name":"Medtronic plc","symbol":"MDT"},"owners":[{"id":155020,"kind":"person","name":"HAKAMI HOOMAN","position":1,"cik":"0001610035","reported_name":"HAKAMI HOOMAN","relationship":{"officer":true,"officer_title":"EVP & Group President Diabetes"}}],"security":"Stock Option (Right to Buy)","published_at":"2018-08-01T15:47:00.000Z","date":"2018-07-30","kind":"grant","acquired":true,"shares":56485,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These options become exercisable at the rate of 25% of the shares granted per year beginning on the first anniversary of grant."}],"balance_after":56485,"derivative":{"exercise_price":89.08,"exercise_date":"2019-07-30","expiration_date":"2028-07-30","underlying":"Ordinary Shares","underlying_shares":56485},"source":{"system":"sec-edgar","filing":"0001127602-18-024239","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1610035/000112760218024239/form4.xml","form_type":"4"}},{"id":3856440,"issuer":{"id":2888,"kind":"organization","name":"Medtronic plc","symbol":"MDT"},"owners":[{"id":155020,"kind":"person","name":"HAKAMI HOOMAN","position":1,"cik":"0001610035","reported_name":"HAKAMI HOOMAN","relationship":{"officer":true,"officer_title":"EVP & Group President Diabetes"}}],"security":"Ordinary Shares","published_at":"2018-08-01T15:47:00.000Z","date":"2018-07-30","kind":"grant","acquired":true,"shares":9355,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The restrictions on these restricted stock units shall lapse 100% on the third anniversary of the Grant Date if the Company's cumulative non-GAAP diluted earnings per share (\"EPS\") growth during the 36-month period ending on the last day of the Company's fiscal year 2021 equals or exceeds a 3% cumulative compound annual growth rate, as determined by the Compensation Committee."}],"balance_after":66472,"source":{"system":"sec-edgar","filing":"0001127602-18-024239","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1610035/000112760218024239/form4.xml","form_type":"4"}},{"id":3857626,"issuer":{"id":2888,"kind":"organization","name":"Medtronic plc","symbol":"MDT"},"owners":[{"id":155020,"kind":"person","name":"HAKAMI HOOMAN","position":1,"cik":"0001610035","reported_name":"HAKAMI HOOMAN","relationship":{"officer":true,"officer_title":"EVP & Group President Diabetes"}}],"security":"Ordinary Shares","published_at":"2018-07-31T15:17:14.000Z","date":"2018-07-28","kind":"tax_withholding","acquired":false,"shares":10038,"price":88.66,"value":889969.08,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"This balance increased by 1,327 shares due to exempt transactions such as dividend reinvestment."}],"balance_after":57117,"source":{"system":"sec-edgar","filing":"0001127602-18-024106","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1610035/000112760218024106/form4.xml","form_type":"4"}},{"id":4103921,"issuer":{"id":2888,"kind":"organization","name":"Medtronic plc","symbol":"MDT"},"owners":[{"id":155020,"kind":"person","name":"HAKAMI HOOMAN","position":1,"cik":"0001610035","reported_name":"HAKAMI HOOMAN","relationship":{"officer":true,"officer_title":"EVP & Group President Diabetes"}}],"security":"Stock Option (Right to Buy)","published_at":"2018-01-08T17:07:54.000Z","date":"2018-01-05","kind":"exercise","acquired":false,"shares":26158,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option to purchase 1,594 ordinary shares of New Medtronic for $62.76 per share, which was unvested at the effective time of the Merger, was received in the Merger and represents the conversion of 1,594 Medtronic common stock shares for $62.76 per share. This New Medtronic stock option has the same terms and conditions as the original Medtronic stock option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"This option to purchase 29,743 New Medtronic ordinary shares for $62.76 per share, which was unvested at the effective time of the Merger, was received in the Merger and represents the conversion of 29,743 Medtronic common stock shares for $62.76 per share. This New Medtronic stock option has the same terms and conditions as the original Medtronic stock option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"This option to purchase 73,296 New Medtronic ordinary shares for $62.76 per share, which was unvested at the effective time of the Merger, was received in the Merger and represents the conversion of 73,296 Medtronic common stock shares for $62.76 per share. This New Medtronic stock option has the same terms and conditions as the original Medtronic stock option."}],"balance_after":26159,"derivative":{"exercise_price":62.76,"expiration_date":"2024-07-28","underlying":"Ordinary Shares","underlying_shares":26158},"source":{"system":"sec-edgar","filing":"0001127602-18-001398","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1610035/000112760218001398/form4.xml","form_type":"4"}},{"id":4103920,"issuer":{"id":2888,"kind":"organization","name":"Medtronic plc","symbol":"MDT"},"owners":[{"id":155020,"kind":"person","name":"HAKAMI HOOMAN","position":1,"cik":"0001610035","reported_name":"HAKAMI HOOMAN","relationship":{"officer":true,"officer_title":"EVP & Group President Diabetes"}}],"security":"Ordinary Shares","published_at":"2018-01-08T17:07:54.000Z","date":"2018-01-05","kind":"sale","acquired":false,"shares":26158,"price":85,"value":2223430.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."}],"balance_after":65828,"source":{"system":"sec-edgar","filing":"0001127602-18-001398","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1610035/000112760218001398/form4.xml","form_type":"4"}},{"id":4103919,"issuer":{"id":2888,"kind":"organization","name":"Medtronic plc","symbol":"MDT"},"owners":[{"id":155020,"kind":"person","name":"HAKAMI HOOMAN","position":1,"cik":"0001610035","reported_name":"HAKAMI HOOMAN","relationship":{"officer":true,"officer_title":"EVP & Group President Diabetes"}}],"security":"Ordinary Shares","published_at":"2018-01-08T17:07:54.000Z","date":"2018-01-05","kind":"exercise","acquired":true,"shares":26158,"price":62.76,"value":1641676.08,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"This balance increased by 356 shares due to exempt transactions such as dividend reinvestment."}],"balance_after":91986,"source":{"system":"sec-edgar","filing":"0001127602-18-001398","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1610035/000112760218001398/form4.xml","form_type":"4"}},{"id":4245192,"issuer":{"id":2888,"kind":"organization","name":"Medtronic plc","symbol":"MDT"},"owners":[{"id":155020,"kind":"person","name":"HAKAMI HOOMAN","position":1,"cik":"0001610035","reported_name":"HAKAMI HOOMAN","relationship":{"officer":true,"officer_title":"EVP & Group President Diabetes"}}],"security":"Stock Option (Right to Buy)","published_at":"2017-08-02T14:56:50.000Z","date":"2017-07-31","kind":"grant","acquired":true,"shares":1191,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These options become exercisable at the rate of 25% of the shares granted per year beginning on the first anniversary of grant."}],"balance_after":1191,"derivative":{"exercise_price":83.97,"exercise_date":"2018-07-31","expiration_date":"2027-07-31","underlying":"Ordinary Shares","underlying_shares":1191},"source":{"system":"sec-edgar","filing":"0001127602-17-024707","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1610035/000112760217024707/form4.xml","form_type":"4"}},{"id":4245191,"issuer":{"id":2888,"kind":"organization","name":"Medtronic plc","symbol":"MDT"},"owners":[{"id":155020,"kind":"person","name":"HAKAMI HOOMAN","position":1,"cik":"0001610035","reported_name":"HAKAMI HOOMAN","relationship":{"officer":true,"officer_title":"EVP & Group President Diabetes"}}],"security":"Stock Option (Right to Buy)","published_at":"2017-08-02T14:56:50.000Z","date":"2017-07-31","kind":"grant","acquired":true,"shares":38109,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These options become exercisable at the rate of 25% of the shares granted per year beginning on the first anniversary of grant."}],"balance_after":38109,"derivative":{"exercise_price":83.97,"exercise_date":"2018-07-31","expiration_date":"2027-07-31","underlying":"Ordinary Shares","underlying_shares":38109},"source":{"system":"sec-edgar","filing":"0001127602-17-024707","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1610035/000112760217024707/form4.xml","form_type":"4"}},{"id":4245190,"issuer":{"id":2888,"kind":"organization","name":"Medtronic plc","symbol":"MDT"},"owners":[{"id":155020,"kind":"person","name":"HAKAMI HOOMAN","position":1,"cik":"0001610035","reported_name":"HAKAMI HOOMAN","relationship":{"officer":true,"officer_title":"EVP & Group President Diabetes"}}],"security":"Ordinary Shares","published_at":"2017-08-02T14:56:50.000Z","date":"2017-07-31","kind":"grant","acquired":true,"shares":9528,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The restrictions on these restricted stock units shall lapse 100% on the third anniversary of the Grant Date if the Company's cumulative non-GAAP diluted earnings per share growth during the 36 month period ending on the last day of the Company's fiscal year 2020 equals or exceeds a 3% cumulative compound annual growth rate, as determined by the Compensation Committee."}],"balance_after":65473,"source":{"system":"sec-edgar","filing":"0001127602-17-024707","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1610035/000112760217024707/form4.xml","form_type":"4"}},{"id":4246974,"issuer":{"id":2888,"kind":"organization","name":"Medtronic plc","symbol":"MDT"},"owners":[{"id":155020,"kind":"person","name":"HAKAMI HOOMAN","position":1,"cik":"0001610035","reported_name":"HAKAMI HOOMAN","relationship":{"officer":true,"officer_title":"EVP & Group President Diabetes"}}],"security":"Ordinary Shares","published_at":"2017-08-01T12:45:37.000Z","date":"2017-07-28","kind":"tax_withholding","acquired":false,"shares":3914,"price":84.29,"value":329911.06,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"This balance increased by 930 shares due to exempt transactions such as dividend reinvestment."}],"balance_after":55945,"source":{"system":"sec-edgar","filing":"0001127602-17-024471","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1610035/000112760217024471/form4.xml","form_type":"4"}},{"id":4399790,"issuer":{"id":2888,"kind":"organization","name":"Medtronic plc","symbol":"MDT"},"owners":[{"id":155020,"kind":"person","name":"HAKAMI HOOMAN","position":1,"cik":"0001610035","reported_name":"HAKAMI HOOMAN","relationship":{"officer":true,"officer_title":"EVP & Group President Diabetes"}}],"security":"Stock Option (Right to Buy)","published_at":"2017-03-06T13:57:47.000Z","date":"2017-03-02","kind":"exercise","acquired":false,"shares":36648,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"This option to purchase 73,296 New Medtronic ordinary shares for $62.76 per share, which was unvested at the effective time of the Merger, was received in the Merger and represents the conversion of 73,296 Medtronic common stock shares for $62.76 per share. This New Medtronic stock option has the same terms and conditions as the original Medtronic stock option."}],"balance_after":52317,"derivative":{"exercise_price":62.76,"expiration_date":"2024-07-28","underlying":"Ordinary Shares","underlying_shares":36648},"source":{"system":"sec-edgar","filing":"0001127602-17-010410","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1610035/000112760217010410/form4.xml","form_type":"4"}},{"id":4399789,"issuer":{"id":2888,"kind":"organization","name":"Medtronic plc","symbol":"MDT"},"owners":[{"id":155020,"kind":"person","name":"HAKAMI HOOMAN","position":1,"cik":"0001610035","reported_name":"HAKAMI HOOMAN","relationship":{"officer":true,"officer_title":"EVP & Group President Diabetes"}}],"security":"Stock Option (Right to Buy)","published_at":"2017-03-06T13:57:47.000Z","date":"2017-03-02","kind":"exercise","acquired":false,"shares":797,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"This option to purchase 1,594 ordinary shares of New Medtronic for $62.76 per share, which was unvested at the effective time of the Merger, was received in the Merger and represents the conversion of 1,594 Medtronic common stock shares for $62.76 per share. This New Medtronic stock option has the same terms and conditions as the original Medtronic stock option."}],"balance_after":88965,"derivative":{"exercise_price":62.76,"expiration_date":"2024-07-28","underlying":"Ordinary Shares","underlying_shares":797},"source":{"system":"sec-edgar","filing":"0001127602-17-010410","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1610035/000112760217010410/form4.xml","form_type":"4"}},{"id":4399788,"issuer":{"id":2888,"kind":"organization","name":"Medtronic plc","symbol":"MDT"},"owners":[{"id":155020,"kind":"person","name":"HAKAMI HOOMAN","position":1,"cik":"0001610035","reported_name":"HAKAMI HOOMAN","relationship":{"officer":true,"officer_title":"EVP & Group President Diabetes"}}],"security":"Stock Option (Right to Buy)","published_at":"2017-03-06T13:57:47.000Z","date":"2017-03-02","kind":"exercise","acquired":false,"shares":14871,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option to purchase 29,743 New Medtronic ordinary shares for $62.76 per share, which was unvested at the effective time of the Merger, was received in the Merger and represents the conversion of 29,743 Medtronic common stock shares for $62.76 per share. This New Medtronic stock option has the same terms and conditions as the original Medtronic stock option."}],"balance_after":89762,"derivative":{"exercise_price":62.76,"expiration_date":"2024-07-28","underlying":"Ordinary Shares","underlying_shares":14871},"source":{"system":"sec-edgar","filing":"0001127602-17-010410","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1610035/000112760217010410/form4.xml","form_type":"4"}},{"id":4399787,"issuer":{"id":2888,"kind":"organization","name":"Medtronic plc","symbol":"MDT"},"owners":[{"id":155020,"kind":"person","name":"HAKAMI HOOMAN","position":1,"cik":"0001610035","reported_name":"HAKAMI HOOMAN","relationship":{"officer":true,"officer_title":"EVP & Group President Diabetes"}}],"security":"Ordinary Shares","published_at":"2017-03-06T13:57:47.000Z","date":"2017-03-02","kind":"sale","acquired":false,"shares":52316,"price":82.327,"value":4307019.332,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price.  The shares were sold in multiple transactions at prices ranging from $82.30 to $82.41, inclusive.  The reporting person undertakes to provide to Medtronic plc, any security holder of Medtronic plc, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"This balance increased by 627 shares due to exempt transactions such as dividend reinvestment."}],"balance_after":58929,"source":{"system":"sec-edgar","filing":"0001127602-17-010410","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1610035/000112760217010410/form4.xml","form_type":"4"}},{"id":4399786,"issuer":{"id":2888,"kind":"organization","name":"Medtronic plc","symbol":"MDT"},"owners":[{"id":155020,"kind":"person","name":"HAKAMI HOOMAN","position":1,"cik":"0001610035","reported_name":"HAKAMI HOOMAN","relationship":{"officer":true,"officer_title":"EVP & Group President Diabetes"}}],"security":"Ordinary Shares","published_at":"2017-03-06T13:57:47.000Z","date":"2017-03-02","kind":"exercise","acquired":true,"shares":36648,"price":62.76,"value":2300028.48,"ownership":{"direct":true},"balance_after":111245,"source":{"system":"sec-edgar","filing":"0001127602-17-010410","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1610035/000112760217010410/form4.xml","form_type":"4"}},{"id":4399785,"issuer":{"id":2888,"kind":"organization","name":"Medtronic plc","symbol":"MDT"},"owners":[{"id":155020,"kind":"person","name":"HAKAMI HOOMAN","position":1,"cik":"0001610035","reported_name":"HAKAMI HOOMAN","relationship":{"officer":true,"officer_title":"EVP & Group President Diabetes"}}],"security":"Ordinary Shares","published_at":"2017-03-06T13:57:47.000Z","date":"2017-03-02","kind":"exercise","acquired":true,"shares":797,"price":62.76,"value":50019.72,"ownership":{"direct":true},"balance_after":74597,"source":{"system":"sec-edgar","filing":"0001127602-17-010410","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1610035/000112760217010410/form4.xml","form_type":"4"}},{"id":4399784,"issuer":{"id":2888,"kind":"organization","name":"Medtronic plc","symbol":"MDT"},"owners":[{"id":155020,"kind":"person","name":"HAKAMI HOOMAN","position":1,"cik":"0001610035","reported_name":"HAKAMI HOOMAN","relationship":{"officer":true,"officer_title":"EVP & Group President Diabetes"}}],"security":"Ordinary Shares","published_at":"2017-03-06T13:57:47.000Z","date":"2017-03-02","kind":"exercise","acquired":true,"shares":14871,"price":62.76,"value":933303.96,"ownership":{"direct":true},"balance_after":73800,"source":{"system":"sec-edgar","filing":"0001127602-17-010410","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1610035/000112760217010410/form4.xml","form_type":"4"}}]}